Galectin Therapeutics, Inc. (GALT)
2.74
-0.02
(-0.72%)
USD |
NASDAQ |
Feb 17, 16:00
2.75
+0.01
(+0.36%)
Pre-Market: 20:00
Galectin Therapeutics Total Liabilities (Quarterly) : 136.44M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
| Imunon, Inc. | 4.906M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.86M |
| Shareholders Equity (Quarterly) | -123.58M |
| Debt to Equity Ratio | -0.9897 |
| Current Ratio | 0.0933 |
| Net Debt Paydown Yield | -2.11% |